NCT06932458View on ClinicalTrials.gov

A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal Metastases

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 17, 2025

Primary Completion Date

June 1, 2028

Study Completion Date

June 1, 2030

Conditions
Testicular Cancer
Interventions
PROCEDURE

Retroperitoneal Lymph Node Dissection

Open bilateral nerve-sparing RPLND.

Trial Locations (1)

Unknown

RECRUITING

London Health Sciences Centre, London

All Listed Sponsors
lead

Western University, Canada

OTHER

NCT06932458 - A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal Metastases | Biotech Hunter | Biotech Hunter